← back to search

Xinzhuang Wang

Harbin Medical University · CN
Area of research
Cancer Research · Agronomy and Crop Science
Research interest
Research interests include Glioma, Biology, Cancer research, Autophagy, Medicine, and Immune system.
h-index
citations
253
works
11
NIH funding
primary concept
email

Recent publications

Proteogenomic characterization of ferroptosis regulators reveals therapeutic potential in glioblastoma
BMC Cancer 2023cited by 13position: firstdoi
RRM2 Mediates the Anti-Tumor Effect of the Natural Product Pectolinarigenin on Glioblastoma Through Promoting CDK1 Protein Degradation by Increasing Autophagic Flux
Frontiers in Oncology 2022cited by 21position: middledoi
Genome Instability-Associated Long Non-Coding RNAs Reveal Biomarkers for Glioma Immunotherapy and Prognosis
Frontiers in Genetics 2022cited by 1position: firstdoi
A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
Frontiers in Genetics 2021cited by 25position: middledoi
A novel lncRNA, RPL34-AS1, promotes proliferation and angiogenesis in glioma by regulating VEGFA
Journal of Cancer 2021cited by 17position: middledoi
Clinical Value of TXNDC12 Combined With IDH and 1p19q as Biomarkers for Prognosis of Glioma
Pathology & Oncology Research 2021cited by 14position: firstdoi
<i>TMEM2</i> Combined with <i>IDH</i> and 1p19q in Refining Molecular Subtypes for Predicting Survival of Patients with Glioma
DNA and Cell Biology 2021cited by 5position: middledoi
An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
Frontiers in Genetics 2020cited by 34position: firstdoi
Identification of hub genes and small-molecule compounds in medulloblastoma by integrated bioinformatic analyses
PeerJ 2020cited by 19position: middledoi
MicroRNA-195 protection against focal cerebral ischemia by targeting CX3CR1
Journal of neurosurgery 2019cited by 42position: middledoi
Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma
Cell Death and Disease 2018cited by 62position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Shiguang Zhao · Harbin Medical University5 papers (2018–2021)Jianing Wu · Sun Yat-sen University4 papers (2018–2022)Qiuyi Jiang · Harbin Medical University4 papers (2020–2022)Ming Gao · Harbin Medical University4 papers (2020–2022)Dayong Han · Harbin Medical University4 papers (2018–2022)Junyi Ye · Fudan University4 papers (2020–2022)Quan Yang · Guangzhou University of Chinese Medicine4 papers (2020–2021)Enzhou Lu · Harbin Medical University3 papers (2021–2022)Xu Hou · Harbin Medical University3 papers (2018–2022)Ming Gao · Chinese Academy of Forestry3 papers (2021–2023)Zhendong Liu · Harbin Medical University3 papers (2018–2020)Yang He · Nanchang University2 papers (2021–2022)Zhixing Zheng · Harbin Medical University2 papers (2018–2022)Dongzhi Zhang · Shandong University2 papers (2021–2022)Zhenying Sun · Harbin Medical University2 papers (2020–2022)Haiping Jiang · California Institute for Regenerative Medicine2 papers (2021–2022)Jian Zhang · Shandong University of Science and Technology2 papers (2020–2021)Ligang Wang · Guangzhou University of Chinese Medicine2 papers (2020–2021)Daming Zhang · Shanxi Medical University2 papers (2018–2019)Xin Chen · Shanghai Medical College of Fudan University2 papers (2021–2022)